Literature DB >> 14726444

Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans.

John N Fain1, Atul K Madan, M Lloyd Hiler, Paramjeet Cheema, Suleiman W Bahouth.   

Abstract

The purpose of this study was to examine the source of adipokines released by the visceral and sc adipose tissues of obese humans. Human adipose tissue incubated in primary culture for 48 h released more prostaglandin E(2), IL-8, and IL-6 than adiponectin, whereas the release of plasminogen activator inhibitor 1 and hepatocyte growth factor was less than that of adiponectin but greater than that of leptin. IL-10 and TNFalpha were released in amounts less than those of leptin, whereas vascular endothelial growth factor and IL1-beta were released in much lower amounts. The accumulation of adipokines was also examined in the three fractions (adipose tissue matrix, isolated stromovascular cells, and adipocytes) obtained by collagenase digestion of adipose tissue. Over 90% of the adipokine release by adipose tissue, except for adiponectin and leptin, could be attributed to nonfat cells. Visceral adipose tissue released greater amounts of vascular endothelial growth factor, IL-6, and plasminogen activator inhibitor 1 compared with abdominal sc tissue. The greatly enhanced total release of TNFalpha, IL-8, and IL-10 by adipose tissue from individuals with a body mass index of 45 compared with 32 was due to nonfat cells. Furthermore, most of the adipokine release by the nonfat cells of adipose tissue was due to cells retained in the tissue matrix after collagenase digestion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14726444     DOI: 10.1210/en.2003-1336

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  396 in total

1.  Epicardial adipose tissue thickness predicts descending thoracic aorta atherosclerosis shown by multidetector computed tomography.

Authors:  Hikmet Yorgun; Uğur Canpolat; Tuncay Hazırolan; Hamza Sunman; Ahmet Hakan Ateş; Kadri Murat Gürses; Ozgür Ertuğrul; Ergün Barış Kaya; Kudret Aytemir; Lale Tokgözoğlu; Giray Kabakçı; Ali Oto
Journal:  Int J Cardiovasc Imaging       Date:  2011-06-03       Impact factor: 2.357

2.  Portal vein and systemic adiponectin concentrations are closely linked with hepatic glucose and lipoprotein kinetics in extremely obese subjects.

Authors:  Faidon Magkos; Elisa Fabbrini; Bruce W Patterson; J Christopher Eagon; Samuel Klein
Journal:  Metabolism       Date:  2011-05-31       Impact factor: 8.694

Review 3.  Obesity in cancer survival.

Authors:  Niyati Parekh; Urmila Chandran; Elisa V Bandera
Journal:  Annu Rev Nutr       Date:  2012-04-23       Impact factor: 11.848

Review 4.  Adipose tissue lymphocytes: types and roles.

Authors:  S Caspar-Bauguil; B Cousin; S Bour; L Casteilla; L Castiella; L Penicaud; C Carpéné
Journal:  J Physiol Biochem       Date:  2009-12       Impact factor: 4.158

5.  Effects of sleep restriction on adiponectin levels in healthy men and women.

Authors:  Norah S Simpson; Siobhan Banks; Sylmarie Arroyo; David F Dinges
Journal:  Physiol Behav       Date:  2010-08-17

6.  The role of production of adipsin and leptin in the development of insulin resistance in patients with abdominal obesity.

Authors:  M A Vasilenko; E V Kirienkova; D A Skuratovskaia; P A Zatolokin; N I Mironyuk; L S Litvinova
Journal:  Dokl Biochem Biophys       Date:  2017-09-02       Impact factor: 0.788

7.  Obesity as a risk factor for severe acute pancreatitis patients.

Authors:  Jana Katuchova; Juraj Bober; Pavol Harbulak; Alexander Hudak; Tomas Gajdzik; Rastislav Kalanin; Jozef Radonak
Journal:  Wien Klin Wochenschr       Date:  2014-02-13       Impact factor: 1.704

8.  Adipocytes enhance murine pancreatic cancer growth via a hepatocyte growth factor (HGF)-mediated mechanism.

Authors:  Kathryn M Ziegler; Robert V Considine; Eben True; Deborah A Swartz-Basile; Henry A Pitt; Nicholas J Zyromski
Journal:  Int J Surg       Date:  2016-03-05       Impact factor: 6.071

9.  Comparison of body composition changes between atazanavir/ritonavir and lopinavir/ritonavir each in combination with tenofovir/emtricitabine in antiretroviral-naïve patients with HIV-1 infection.

Authors:  Graeme J Moyle; Hélène Hardy; Awny Farajallah; Michelle DeGrosky; Donnie McGrath
Journal:  Clin Drug Investig       Date:  2014-04       Impact factor: 2.859

Review 10.  Adipose tissue biology and cardiomyopathy: translational implications.

Authors:  Aslan T Turer; Joseph A Hill; Joel K Elmquist; Philipp E Scherer
Journal:  Circ Res       Date:  2012-12-07       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.